Contact
Please use this form to send email to PR contact of this press release:
Live attenuated SARS-CoV-2 vaccine candidate adaptable to emerging SARS-CoV-2 variants
TO:
Please use this form to send email to PR contact of this press release:
Live attenuated SARS-CoV-2 vaccine candidate adaptable to emerging SARS-CoV-2 variants
TO: